Viridian Therapeutics Inc
VRDN
$19.56+6.42%
End of day · as of Oct 16, 2026, 8:31 AM ET
Mkt cap
$1.39B
EV/Sales
7.28
P/E ratio
N/A
FY2025 Revenue
$70.85M
EPS (FY2025)
N/A
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-483.57%
Beta
0.46
Div yield
N/A
Sector
Healthcare
Viridian Therapeutics Inc (VRDN) is a biotechnology company listed on US.
Latest reported VRDN revenue for 2025-12-31 was $70.8M. Net income was -$342.6M. Revenue was up 23359.9% from 2024-12-31 to 2025-12-31. VRDN currently screens at market cap $1.39B.
Use this VRDN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full VRDN income, balance, and cash tables.
Viridian Therapeutics Inc (VRDN) is a biotechnology company in the Healthcare sector.
Latest cached Viridian Therapeutics Inc (VRDN) revenue for Dec 31, 2025 was $70.8M. Net income was -$342.6M. Statements: https://lician.com/financials/vrdn
Viridian Therapeutics Inc (VRDN) market capitalization is $1.39B on the latest cached snapshot.
Viridian Therapeutics Inc (VRDN) cached previous close $18.38; day range $18.69 – $19.56; volume 2,135,681. Session quote: https://lician.com/quote/vrdn
Viridian Therapeutics Inc (VRDN) latest cached earnings event is "VRDN earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached VRDN filing is 8-K · Aug 6, 2026. Filings: https://lician.com/sec/vrdn